Literature DB >> 7981833

Analysis of DNA restriction fragments and polymerase chain reaction products by capillary electrophoresis.

P E Williams1, M A Marino, S A Del Rio, L A Turni, J M Devaney.   

Abstract

Capillary electrophoresis (CE) is a new, high-resolution tool for the analysis of DNA restriction fragments and DNA amplified by the polymerase chain reaction (PCR). By combining many of the principles of traditional slab gel methods in a capillary format, it is possible to perform molecular size determinations of human and plant PCR amplification products and DNA restriction fragments. DNA restriction fragments and PCR products were analyzed by dynamic sieving electrophoresis (DSE) and capillary gel electrophoresis (CGE). As part of this study, sample preparation procedures, injection modes, and the use of molecular mass markers were evaluated. Optimum separations were performed using the uPage-3 (3% T, 3% C) CGE columns with UV detection at 260 nm. Membrane dialysis and ultrafiltration/centrifugation proved to be nearly equivalent methods of sample preparation. Reproducibility studies demonstrated that blunt-ended, non-phosphorylated markers (specifically allele generated markers) provide the most accurate calibration for PCR product analysis. This study demonstrates that CE offers a high-speed, high-resolution analytical method for accurately determining molecular size and/or allelic type as compared with traditional methodologies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981833     DOI: 10.1016/0021-9673(94)85152-2

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  High-precision genotyping by denaturing capillary electrophoresis.

Authors:  H Wenz; J M Robertson; S Menchen; F Oaks; D M Demorest; D Scheibler; B B Rosenblum; C Wike; D A Gilbert; J W Efcavitch
Journal:  Genome Res       Date:  1998-01       Impact factor: 9.043

2.  First experiences with the Spectrum Compact CE System.

Authors:  Nastasja Burgardt; Melanie Weissenberger
Journal:  Int J Legal Med       Date:  2021-10-19       Impact factor: 2.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.